Daily FNArena News - Small Caps

While Mayne Pharma’s weak sales are disappointing, brokers point to the long-term potential of the stock.

Technology One’s potential in cloud software is unquestioned but brokers remain concerned about the near-term revenue impact from migrating customers.

Capilano Honey has substantially increased market share and a bumper profit is forecast for FY15.

Only a few months into its life as an ASX-listed entity, Ashley Services has significantly expanded its contract base.

Data centre provider NextDC is moving from strength to strength, bringing forward forecasts for profitability by around six months.

Fledgling data security provider Covata has achieved product commercialisation and is rapidly reaching for the clouds.

Residential developer Peet has acquired stakes of varying sizes in six projects with approval from brokers.

Moelis is unconcerned about the rally in Netcomm’s shares, believing the company’s trajectory is sound.

Poseidon Nickel has raised its profile as an emerging producer with two significant new assets to complement its Windarra project.

Brokers are keenly anticipating the results of Sirtex Medical’s study on colorectal cancer treatment which, if successful, could trigger upside for the stock.